Although they are usually not a significant concern, common ones like nausea, diarrhea, or appetite loss might occur
This medication is sold in a few forms: Ozempic (injectable): approved in2017for lowering blood sugar levels in adults with type 2 diabetes, as well as reducing the risk of heart attack, stroke, or death in those with type 2 diabetes and heart disease Rybelsus (tablet): approved in2019as the first and only GLP-1 analog in pill form and indicated to improve blood sugar regulation in adults with type 2 diabetes Wegovy (injectable): approved in2021for weight management Use of Rybelsus and Ozempic for weight loss is considered However, to maintain the weight loss benefits of semaglutide, people need to continue taking it
That frustration, seeing a neighbor respond quickly while you wait, is real, and it usually stems from differences in dosing histories and physiological factors rather than treatment failure
Ozempic patients are encouraged to stay vigilant for symptoms such as swelling, pain, redness in the legs, sudden shortness of breath, chest pain, and unexplained coughing
This mechanism significantly reduces the risk of hypoglycaemia (dangerously low blood sugar) compared to some other diabetes medications
Semaglutide activates only the GLP-1 pathway
